Edwards Lifesciences has announced the results of a health economics study across nine European countries, led by York Health Economics Consortium, which it says has shown that early transcatheter aortic valve implantation (TAVI) for asymptomatic severe aortic stenosis (AS) patients delivers significant economic benefits alongside improved clinical outcomes. The simulation estimates lifetime per-patient savings between […] The post Cost analysis suggests benefit of early TAVI in asymptomatic aortic stenosis appeared first on Cardiovascular News .